AstraZeneca punts midphase cardiovascular prospect to startup
AstraZeneca punts midphase cardiovascular prospect to startup ntaylor Thu, 02/03/2022 [...]
Gilead’s CD47 clinical hold expands as CEO O’Day expresses ‘sense of urgency’ in getting trials back on track
Gilead’s CD47 clinical hold expands as CEO O’Day expresses ‘sense [...]
FDA puts LogicBio genome editing therapy trial on hold after 2nd infant suffers adverse event
FDA puts LogicBio genome editing therapy trial on hold after [...]
Novartis JAKs in rival to Incyte’s topical eczema drug after seeing clinical data
Novartis JAKs in rival to Incyte’s topical eczema drug after [...]
Doctor groups urge Biden administration to disclose costs of federally funded clinical trials
Doctor groups urge Biden administration to disclose costs of federally [...]
Anavex touts ‘very large’ phase 3 win for Rett syndrome drug—2 weeks after moving study’s goalposts
Anavex touts ‘very large’ phase 3 win for Rett syndrome [...]
Takeda shunts jewel of Shire takeover to new spinoff Oak Hill
Takeda shunts jewel of Shire takeover to new spinoff Oak [...]
Gamida Cell readies stem cell transplant therapy for FDA submission but seeks strategic partners amid staffing cuts
Gamida Cell readies stem cell transplant therapy for FDA submission [...]
Madrigal’s NASH prospect clears first phase 3 test, raising hopes it can magic up positive pivotal efficacy data
Madrigal’s NASH prospect clears first phase 3 test, raising hopes [...]
Pfizer ends $3B drug dream despite phase 2b success, leaving Regeneron with a clear run at cardiovascular market
Pfizer ends $3B drug dream despite phase 2b success, leaving [...]